

Cover Story
José Baselga, who has resigned from his positions as physician-in-chief and chief medical officer at Memorial Sloan Kettering Cancer Center, is winding down his research and clinical activities at that institution, officials said.
By Matthew Bin Han Ong
In Brief


Drugs & Targets
Trending Stories
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature” - Bhattacharya: New grant review criterion is “not political”
- With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shut down
- Population-based cancer surveillance is a national treasure at risk
- Ci4CC’s 24th Symposium & Workshop set to focus on precision oncology powered by data intelligence